Skip to main content

Test Price

2,800 AED

✅ Home Collection Available

PMP22 Gene Dejerine-Sottas Disease Genetic Test in UAE | 2800 AED | 2026 DHA Guidelines

تحليل جين PMP22 لمرض ديجيرين-سوتاس عبر التسلسل الجيني المتقدم (NGS) في الإمارات | 2800 درهم | معتمد من هيئة الصحة بدبي

الملخص التنفيذي: يقدم اختبار تحليل الجين PMP22 لمرض ديجيرين-سوتاس عبر التسلسل المتقدم (NGS) دقة تشخيصية تتجاوز 99.9%، مع خدمة سحب منزلي متميزة، ودعم إرشادي بعد الاختبار، والتحقق من التأمين الصحي عبر الواتساب.

Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO Accredited Processing.
Premium Logistics: Paid Hospital-Grade Home Collection via ISO Certified Cold-Chain Home Collection and VIP Mobile Phlebotomy (8 AM - 11 PM daily).
Clinical Guidance: Telephonic Post-Test Clinical Guidance in result interpretation.
Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.

Test Overview

The PMP22 Gene Dejerine-Sottas Disease Genetic Test employs Next‑Generation Sequencing to detect pathogenic variants in the peripheral myelin protein 22 gene, providing a definitive molecular diagnosis for severe early‑onset hereditary neuropathy. يستخدم هذا الاختبار التسلسل المتقدم لتحديد الطفرات الجينية المسببة لمرض ديجيرين-سوتاس.

ICD-10 Coverage: G60.0, Z13.71, Z84.8 | LOINC: 81246-0

Feature Our Test (NGS + CNV Analysis) Closest Alternative (Sanger Sequencing)
Precision ≥99.9% diagnostic sensitivity, detects both SNVs and copy number variations (CNVs) ~95% for point mutations; misses large duplications/deletions
Method NGS with CNV‑calling bioinformatics, ACMG 2026 compliance Targeted Sanger sequencing of exonic regions only
Speed 3–4 weeks from sample collection 6–8 weeks for full gene scan

Physician Insight & Safety Protocol

“As a neurologist, I emphasize that a positive PMP22 genetic result must be correlated with clinical and electrophysiological findings; a negative result does not rule out all hereditary neuropathies. This test is a powerful tool when interpreted alongside a thorough family history and genetic counselling.” — Dr. PRABHAKAR REDDY (DHA: 61713011)

“Please remember, genetic testing can reveal unexpected information; the emotional and familial impact should be discussed with a certified genetic counsellor. We ensure pre‑ and post‑test support to navigate your care journey.”

“Decisions about treatment — such as physical therapy, orthopedic interventions, or medication — should never rely solely on a genetic report. Always discuss results with your primary physician before making any changes.”

Safety & Exclusion Criteria

  • Medication Warning: Do not discontinue any prescribed medication without consulting your treating doctor.
  • Exclusion: Individuals incapable of giving informed consent (minors must have guardian consent per UAE CDS Law 2026).
  • Exclusion: Active febrile illness or acute decompensation that might compromise sample stability.
  • ER Red Flags: If you experience rapidly progressive weakness, respiratory distress, or severe pain, seek emergency care immediately — do not delay for elective testing.

Patient FAQ & Clinical Guidance

What is the PMP22 gene Dejerine‑Sottas disease NGS test?

The PMP22 NGS test analyzes the peripheral myelin protein 22 gene for pathogenic variants causing severe early‑onset hereditary motor and sensory neuropathy. يحلل اختبار جين PMP22 عبر التسلسل المتقدم الجين المسؤول عن مرض ديجيرين-سوتاس الوراثي الشديد.

How is the performed and what sample is required?

A simple blood draw, extracted DNA, or a single drop on an FTA card is all that is needed; DNA is then sequenced using high‑coverage NGS, with results delivered in 3–4 weeks. كل ما تحتاجه هو عينة دم بسيطة أو قطرة واحدة على بطاقة FTA ليتم تحليل الحمض النووي بتقنية التسلسل المتقدم.

What happens after I receive my results?

You will receive a detailed clinical report and a scheduled telephonic consultation with Dr. Reddy to interpret the genetic findings, discuss implications, and plan next steps. ستحصل على تقرير طبي مفصل وجلسة استشارية هاتفية مع الدكتور ريدي لفهم النتائج وتخطيط الرعاية المستقبلية.

Regulatory & Accreditation

This service strictly adheres to Federal Decree‑Law No. 41 of 2024 on Medical Liability, UAE Child Data Security Law (2026) for minors, and UAE Personal Data Protection Law. Your genetic data is encrypted and handled with full patient confidentiality. ISO 9001:2015 Certified (Cert: INT/EGQ/2509DA/3139) | DHA Facility License: 9834453.

دعم ثنائي اللغة متاح

التحقق من التغطية التأمينية

Check Insurance Coverage Instantly

Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.

توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.

✅ DHA Certified ✅ ISO 15189 ✅ HIPAA Compliant

Available in Arabic, English, Hindi & Urdu

🏅

ISMS 27001:2022

📋

ISO Accredited

🔒

HIPAA

All reports reviewed by DHA-Certified physicians